These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1531928)

  • 21. Management of onychomycosis with oral terbinafine.
    Zaias N
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):810-2. PubMed ID: 2146293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
    De Backer M; De Keyser P; De Vroey C; Lesaffre E
    Br J Dermatol; 1996 Jun; 134 Suppl 46():16-7: discussion 38. PubMed ID: 8763462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of toe-nail onychomycosis treated with terbinafine.
    Brandrup F; Larsen PO
    Acta Derm Venereol; 1997 May; 77(3):238. PubMed ID: 9188883
    [No Abstract]   [Full Text] [Related]  

  • 24. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
    Tosti A; Piraccini BM; Stinchi C; Colombo MD
    Dermatology; 1998; 197(2):162-6. PubMed ID: 9732167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.
    Faergemann J; Anderson C; Hersle K; Hradil E; Nordin P; Kaaman T; Molin L; Pettersson A
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):750-3. PubMed ID: 7722020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid response of Trichophyton tonsurans-induced onychomycosis after treatment with terbinafine.
    Aly R; Hafeez ZH; Rodwell C; Frieden IJ; Abrams B
    Int J Dermatol; 2002 Jun; 41(6):357-9. PubMed ID: 12100692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine.
    Watson AB; Marley JE; Ellis DH; Williams TG
    Australas J Dermatol; 1998 Feb; 39(1):29-30. PubMed ID: 9529685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of terbinafine in treating onychomycosis in children: clinical observation of 88 cases].
    Wen J; Lin ZF
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):582-3. PubMed ID: 15897144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
    Salo H; Pekurinen M
    Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
    Ranawaka RR; Nagahawatte A; Gunasekara TA; Weerakoon HS; de Silva SH
    J Dermatolog Treat; 2016 Aug; 27(4):364-72. PubMed ID: 26651495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open randomized comparison of itraconazole versus terbinafine in onychomycosis.
    Arenas R; Domínguez-Cherit J; Fernández LM
    Int J Dermatol; 1995 Feb; 34(2):138-43. PubMed ID: 7737776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-dermatophytes in onychomycosis of the toenails.
    Ellis DH; Watson AB; Marley JE; Williams TG
    Br J Dermatol; 1997 Apr; 136(4):490-3. PubMed ID: 9155945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.
    Epstein E
    Arch Dermatol; 1998 Dec; 134(12):1551-4. PubMed ID: 9875192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
    Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
    Heikkilä H; Stubb S
    Br J Dermatol; 2002 Feb; 146(2):250-3. PubMed ID: 11903235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
    Bräutigam M
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.